Narvanen A, Puolakkainen M, Hao W, Kino K, Suni J
Infect Dis Obstet Gynecol. 1997; 5(5):349-54.
PMID: 18476184
PMC: 2364578.
DOI: 10.1155/S1064744997000616.
Maria Marcelino J, Barroso H, Goncalves F, Silva S, Novo C, Gomes P
J Clin Microbiol. 2006; 44(2):607-11.
PMID: 16455923
PMC: 1392652.
DOI: 10.1128/JCM.44.2.607-611.2006.
Barin F, Meyer L, Lancar R, Deveau C, Gharib M, Laporte A
J Clin Microbiol. 2005; 43(9):4441-7.
PMID: 16145089
PMC: 1234099.
DOI: 10.1128/JCM.43.9.4441-4447.2005.
Dresing K, Pouwels C, Bonsack S, Oellerich M, Schworer H, Uy A
Chirurg. 2003; 74(11):1026-33.
PMID: 14605720
DOI: 10.1007/s00104-003-0741-4.
Merat R, Raoul H, Leste-Lasserre T, Sonigo P, Pancino G
J Virol. 1999; 73(7):5698-706.
PMID: 10364320
PMC: 112629.
DOI: 10.1128/JVI.73.7.5698-5706.1999.
Retention of viral infectivity after extensive mutation of the highly conserved immunodominant domain of the feline immunodeficiency virus envelope.
Pancino G, Sonigo P
J Virol. 1997; 71(6):4339-46.
PMID: 9151822
PMC: 191650.
DOI: 10.1128/JVI.71.6.4339-4346.1997.
Species-, serogroup-, and serovar-specific epitopes are juxtaposed in variable sequence region 4 of the major outer membrane proteins of some Chlamydia trachomatis serovars.
Batteiger B, Lin P, Jones R, Van Der Pol B
Infect Immun. 1996; 64(7):2839-41.
PMID: 8698520
PMC: 174151.
DOI: 10.1128/iai.64.7.2839-2841.1996.
Discrimination between human T-cell lymphotropic virus type I and II (HTLV-I and HTLV-II) infections by using synthetic peptides representing an immunodominant region of the core protein (p19) of HTLV-I and HTLV-II.
Bonis J, Baillou A, Barin F, Verdier M, Janvier B, Denis F
J Clin Microbiol. 1993; 31(6):1481-5.
PMID: 8314990
PMC: 265565.
DOI: 10.1128/jcm.31.6.1481-1485.1993.
Peptide immunogen mimicry of putative E1 glycoprotein-specific epitopes in hepatitis C virus.
Ray R, Khanna A, Lagging L, Meyer K, Choo Q, Ralston R
J Virol. 1994; 68(7):4420-6.
PMID: 8207814
PMC: 236366.
DOI: 10.1128/JVI.68.7.4420-4426.1994.
Enzyme immunoassay using native envelope glycoprotein (gp160) for detection of human immunodeficiency virus type 1 antibodies.
Nair B, Ford G, Kalyanaraman V, Zafari M, Fang C, Sarngadharan M
J Clin Microbiol. 1994; 32(6):1449-56.
PMID: 8077388
PMC: 264018.
DOI: 10.1128/jcm.32.6.1449-1456.1994.
Structural analysis of the principal immunodominant domain of the feline immunodeficiency virus transmembrane glycoprotein.
Pancino G, Camoin L, Sonigo P
J Virol. 1995; 69(4):2110-8.
PMID: 7884857
PMC: 188877.
DOI: 10.1128/JVI.69.4.2110-2118.1995.
IgG subclass response to HIV in relation to antibody-dependent cellular cytotoxicity at different clinical stages.
Ljunggren K, Broliden P, Jondal M, Wahren B
Clin Exp Immunol. 1988; 73(3):343-7.
PMID: 3208446
PMC: 1541760.
Practical diagnostic testing for human immunodeficiency virus.
Jackson J, Balfour Jr H
Clin Microbiol Rev. 1988; 1(1):124-38.
PMID: 3060241
PMC: 358034.
DOI: 10.1128/CMR.1.1.124.
Comparison of 10 enzyme immunoassays for detection of antibody to human immunodeficiency virus type 2 in West African sera.
Denis F, Leonard G, Sangare A, Rey J, Soro B, Schmidt D
J Clin Microbiol. 1988; 26(5):1000-4.
PMID: 2838498
PMC: 266504.
DOI: 10.1128/jcm.26.5.1000-1004.1988.
Screening of African sera stored for more than 17 years for HIV antibodies by site-directed serology.
Chiodi F, Biberfeld G, Parks E, Norrby E, MUFSON M
Eur J Epidemiol. 1989; 5(1):42-6.
PMID: 2707394
DOI: 10.1007/BF00145043.
Immunofluorescence assay for detection of antibodies to human immunodeficiency virus type 2.
Kvinesdal B, Nielsen C, POULSEN A, Hojlyng N
J Clin Microbiol. 1989; 27(11):2502-4.
PMID: 2681251
PMC: 267066.
DOI: 10.1128/jcm.27.11.2502-2504.1989.
Differential diagnosis of human retrovirus infections in the laboratory.
Griffith B
Yale J Biol Med. 1989; 62(2):103-14.
PMID: 2549735
PMC: 2589209.
A synthetic peptide defines a serologic IgA response to a human papillomavirus-encoded nuclear antigen expressed in virus-carrying cervical neoplasia.
Dillner J, Dillner L, Robb J, Willems J, Jones I, Lancaster W
Proc Natl Acad Sci U S A. 1989; 86(10):3838-41.
PMID: 2471193
PMC: 287236.
DOI: 10.1073/pnas.86.10.3838.
Envelope cross-reactivity between human immunodeficiency virus types 1 and 2 detected by different serological methods: correlation between cross-neutralization and reactivity against the main neutralizing site.
Bottiger B, Karlsson A, Andreasson P, Naucler A, Costa C, Norrby E
J Virol. 1990; 64(7):3492-9.
PMID: 2191152
PMC: 249614.
DOI: 10.1128/JVI.64.7.3492-3499.1990.
Identification of a uniquely immunodominant, cross-reacting site in the human immunodeficiency virus endonuclease protein.
Bjorling E, Utter G, Stalhandske P, Norrby E, Chiodi F
J Virol. 1991; 65(8):4543-6.
PMID: 2072463
PMC: 248902.
DOI: 10.1128/JVI.65.8.4543-4546.1991.